Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
7.74Price to Sales
VS
Market
Sector
Industry
History
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information
Ticker
SAGECompany Name
SAGE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSAGE THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SAGE - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 544.97M | 7.74 | $ 70.41M |
| 3/31/2025 | $ 475.92M | 10.04 | $ 47.4M |
| 12/31/2024 | $ 442.05M | 10.72 | $ 41.24M |
| 9/30/2024 | $ 518.75M | 4.88 | $ 106.4M |
| 6/30/2024 | $ 668.5M | 6.87 | $ 97.24M |
| 3/31/2024 | $ 817.27M | 8.97 | $ 91.06M |
| 12/31/2023 | $ 1.55B | 17.9 | $ 86.45M |
| 9/30/2023 | $ 1.18B | 103.72 | $ 11.35M |
| 6/30/2023 | $ 1B | 96.71 | $ 10.37M |
| 3/31/2023 | $ 2.72B | 289.62 | $ 9.4M |
Key Performance Insights, Last 5 Years
- SAGE THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 582.91.
- Over the past 5 years, SAGE THERAPEUTICS INC's average P/S has been 139.34.
- The median P/S for SAGE THERAPEUTICS INC during this period was 14.31
- SAGE THERAPEUTICS INC reached its highest P/S over the past 5 years at 582.91.
- The lowest P/S recorded by SAGE THERAPEUTICS INC in the same timeframe 2.2
SAGE THERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for SAGE THERAPEUTICS INC is calculated as follows: Market Cap [ $ 4.07B ] / Revenues [ $ 6.97M ]
(=) P/S [ 582.91 ] SAGE - Price to Sales, Last 5 years
2.2
Minimum
Jun 30, 2021
582.91
Maximum
Sep 30, 2020
139.34
Average
14.31
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |